We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.AGREEMENT AND PLAN OF MERGER by and among PIERIS PHARMACEUTICALS, INC., POLO MERGER SUB, INC. and PALVELLA THERAPEUTICS, INC. Dated as of July 23, 2024Merger Agreement • July 24th, 2024 • Pieris Pharmaceuticals, Inc. • Pharmaceutical preparations • Nevada
Contract Type FiledJuly 24th, 2024 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of July 23, 2024, is entered into by and among Pieris Pharmaceuticals, Inc., a Nevada corporation (“Public Company”), Polo Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Public Company (the “Merger Sub”), and Palvella Therapeutics, Inc. a Delaware corporation (“Merger Partner”).
AGREEMENT AND PLAN OF MERGER by and among PIERIS PHARMACEUTICALS, INC., POLO MERGER SUB, INC. and PALVELLA THERAPEUTICS, INC. Dated as of July 23, 2024Merger Agreement • July 24th, 2024 • Pieris Pharmaceuticals, Inc. • Pharmaceutical preparations • Nevada
Contract Type FiledJuly 24th, 2024 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of July 23, 2024, is entered into by and among Pieris Pharmaceuticals, Inc., a Nevada corporation (“Public Company”), Polo Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Public Company (the “Merger Sub”), and Palvella Therapeutics, Inc. a Delaware corporation (“Merger Partner”).
AGREEMENT AND PLAN OF MERGER among Sphere 3D Corp. and Gryphon Digital Mining, Inc. and Sphere GDM Corp. dated as of June 3, 2021 AGREEMENT AND PLAN OF MERGERMerger Agreement • May 12th, 2023 • Akerna Corp. • Services-computer processing & data preparation • Delaware
Contract Type FiledMay 12th, 2023 Company Industry JurisdictionThis Agreement and Plan of Merger (this “Agreement”), dated as of June 3, 2021, is entered into by and among Sphere 3D Corp., an Ontario corporation (“Parent”) (“Public Company”); Sphere GDM Corp., a Delaware corporation and a wholly owned subsidiary of Public Company (the “Merger Sub”); and Gryphon Digital Mining, Inc., a Delaware corporation (“Merger Partner”).
AGREEMENT AND PLAN OF MERGER among Sphere 3D Corp. and Gryphon Digital Mining, Inc. and Sphere GDM Corp. dated as of June 3, 2021Merger Agreement • August 6th, 2021 • Sphere 3D Corp • Services-computer processing & data preparation • Delaware
Contract Type FiledAugust 6th, 2021 Company Industry JurisdictionThis Agreement and Plan of Merger (this "Agreement"), dated as of June 3, 2021, is entered into by and among Sphere 3D Corp., an Ontario corporation ("Parent") ("Public Company"); Sphere GDM Corp., a Delaware corporation and a wholly owned subsidiary of Public Company (the "Merger Sub"); and Gryphon Digital Mining, Inc., a Delaware corporation ("Merger Partner").
AGREEMENT AND PLAN OF MERGERMerger Agreement • March 29th, 2021 • Millendo Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 29th, 2021 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of March 29, 2021, is entered into by and among Millendo Therapeutics, Inc., a Delaware corporation (“Public Company”); Mars Merger Corp., a Delaware corporation and a wholly owned subsidiary of Public Company (the “Merger Sub”); and Tempest Therapeutics, Inc., a Delaware corporation (“Merger Partner”).
AGREEMENT AND PLAN OF MERGER by and among CHANTICLEER Holdings, Inc. a Delaware corporation Biosub INc. a Delaware corporation and Sonnet BioTherapeutics, Inc. a New Jersey corporation dated as of October 10, 2019Merger Agreement • June 3rd, 2020 • Amergent Hospitality Group, Inc • Retail-eating & drinking places • Delaware
Contract Type FiledJune 3rd, 2020 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of October 10, 2019, is entered into by and among CHANTICLEER HOLDINGS, INC., a Delaware corporation (“Public Company”); BIOSUB INC., a Delaware corporation and a wholly owned subsidiary of Public Company (the “Merger Sub”); and SONNET BIOTHERAPEUTICS, INC., a New Jersey corporation (“Merger Partner,” and together with Public Company and the Merger Sub, the “Parties”).
AGREEMENT AND PLAN OF MERGER by and among CHANTICLEER Holdings, Inc. a Delaware corporation Biosub INc. a Delaware corporation and Sonnet BioTherapeutics, Inc. a New Jersey corporation dated as of October 10, 2019Merger Agreement • October 11th, 2019 • Chanticleer Holdings, Inc. • Retail-eating places • Delaware
Contract Type FiledOctober 11th, 2019 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of October 10, 2019, is entered into by and among CHANTICLEER HOLDINGS, INC., a Delaware corporation (“Public Company”); BIOSUB INC., a Delaware corporation and a wholly owned subsidiary of Public Company (the “Merger Sub”); and SONNET BIOTHERAPEUTICS, INC., a New Jersey corporation (“Merger Partner,” and together with Public Company and the Merger Sub, the “Parties”).